The acute and chronic pharmacokinetics and pharmacodynamics of oral cannabidiol with and without low doses of delta-9-tetrahydrocannabinol

20251 citationsJournal Articlehybrid Open Access

Authors

David Isaac Wolinsky · Johns Hopkins University

C. Austin Zamarripa · Johns Hopkins University

Tory R. Spindle · Johns Hopkins University

Mitchell Klausner · Johns Hopkins University

E. J. Cone · Johns Hopkins University

Ruth E. Winecker · RTI International

Svante Vikingsson ·

Abstract

Individuals subject to drug testing should recognize that hemp products contain detectable amounts of Δ9-THC. Conventional drug testing cannot reliably distinguish between illicit cannabis and legal hemp-derived product use, and a positive urine Δ9-THC test may result from low doses that do not produce intoxication or impairment.

Topics & Keywords

Cannabis and Cannabinoid Research Epilepsy research and treatment Forensic Toxicology and Drug Analysis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Analytical Toxicology

DOI: 10.1093/jat/bkaf075

Field-Weighted Citation Impact: 1.41